Navigation Links
Kendle Executives to Share Insights at 20th Annual Partnerships in Clinical Trials Conference
Date:3/28/2011

CINCINNATI, March 28, 2011 /PRNewswire/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced several of its executives will speak on key industry issues at the 20th Annual Partnerships in Clinical Trials Conference March 30 to April 1, 2011, in Phoenix, Ariz. Kendle experts will address the impact of pharma industry mergers and acquisitions on outsourcing strategies as well as best practices for patient recruitment and retention.  Kendle also will host a "Quiz our Experts" interactive Q&A session March 31 from 3:45 to 4:15 p.m. in Booth #301 on the showroom floor to address questions and share insights with customers on key clinical development issues.

Participating on the executive panel "Sponsors and CROs Unplugged – Assess the Impact of M&A On Your Outsourcing Strategy" on Thursday, March 31 at 11:45 a.m. will be Stephen Cutler, PhD, Kendle's current Senior Vice President and Chief Operating Officer who will assume the role of President and Chief Executive Officer on May 1. With more than 20 years of senior management and operations leadership experience in the CRO and biopharmaceutical industries, Dr. Cutler has extensive experience in the development and delivery of successful partnerships between CROs and their customers (for a recent interview with Dr. Cutler in Pharmaceutical Outsourcing on how strategic partnerships with CROs can lead  to  more  cost-effective clinical development efforts, please visit http://www.kendle.com/uploads/PharmaOutsourcing0311_Cutler.pdf).

Also representing Kendle at the conference will be Jeff Zucker, Senior Director and Global Head, Patient Recruitment on the topic of best practices in patient recruitment; as well as a panel of Kendle executives featuring Mr. Zucker; Mark Roseman, DSc, Senior Vice President, Sales and Chief Marketing Officer; and Thomas O'Donnell, Vice President, Strategic Alliances, moderated by John Macdonald, Vice President, New Business Development – Europe and Asia/Pacific. Kendle Speakers at Partnerships in Clinical TrialsThursday, March 31, 11:45 a.m.  – Track SSponsors and CROs Unplugged – Assess the Impact of M&A On Your Outsourcing StrategyStephen Cutler, PhDSenior Vice President and Chief Operating OfficerThursday, March 31, 3:45 – 4:15 p.m. – Kendle Booth #301Quiz Our ExpertsModerator: John Macdonald, Vice President, New Business Development – Europe and Asia/PacificPanelists: Mark Roseman, DSc, Senior Vice President, Sales and Chief Marketing Officer; Thomas O'Donnell, Vice President, Strategic Alliances; and Jeff Zucker, Senior Director and Global Head, Patient RecruitmentFriday, April 1, 11:45 a.m. – Track OBest Practices for Patient Recruitment and Retention in Clinical TrialsJeff ZuckerSenior Director and Global Head, Patient RecruitmentVisit Kendle at Booth #301Kendle speakers and additional senior clinical development experts will be available at Booth #301 for on-site meetings and to discuss the Company's approach to successful partnerships – focusing on quality, delivery and efficiency to bring greater innovation and value to the clinical development process.

About KendleKendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing products to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's website at www.kendle.com.


'/>"/>

SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kendle Announces Fourth Quarter and Full-Year 2010 Results
2. Kendle Appoints Martha Feller, PhD, Vice President and Global Head, Study Start-up
3. Kendle Announces CEO Succession Plan, Promotes Stephen Cutler, PhD, to President and CEO
4. Kendle to Present at Lazard Capital Markets 7th Annual Healthcare Conference
5. Kendle Announces Details Regarding Third Quarter 2010 Earnings Conference Call and Webcast
6. Kendle Appoints Mark J. Roseman, D.Sc., Senior Vice President and Chief Marketing Officer
7. Kendle Announces Details Regarding Second Quarter 2010 Earnings Conference Call and Webcast
8. Kendle to Present at 2010 Wells Fargo Securities Healthcare Conference
9. Kendle Advances Early Stage Drug Development with ElMindAs Innovative Brain Network Activation Technology
10. Kendle Director of Global Safety and Pharmacovigilance, Drew Kilpatrick, PhD, Named One of Ten Notable People in R&D
11. Kendle Executive to Share Insights at World Pharma Trials Asia 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... , Jan. 16, 2017 Infusion ... devices used for administering medications in a controlled, ... used for therapeutic purposes in critical care, pain ... required to make patient,s feel comfortable and pain ... errors which would lead to serious life threatening ...
(Date:1/16/2017)... 2017 Derek H. Potts , founder ... recently appointed Liaison Counsel in California,s ... cases. In this role, Potts was assigned to serve ... assist the Court and Co Lead Plaintiff,s Counsel. Co-Counsel ... Jackson Fairchild & Wade and Ruth Rizkalla ...
(Date:1/16/2017)... TORONTO , Jan. 16, 2017 When synthetic ... to market their product as top-rate. They offered free samples, ... top-notch customer service. Soon, business was booming. ... often described as 100 times more powerful than morphine, has ... in last 2 years. One dealer,s recorded fentanyl ...
Breaking Medicine Technology:
(Date:1/16/2017)... ... January 17, 2017 , ... Recently, patients and staff ... Michigan, joined other volunteers and organizations in support of the annual Binder Park Zoo ... families dressed up in colorful costumes of all designs coming out to enjoy games, ...
(Date:1/16/2017)... ... , ... With the Grand Opening Event planned for February 3, 2017, the ... and the general public. Built in five months by Centerpoint, the 60,000 square foot ... or pickleball courts. The space is also suitable for indoor soccer and football training. ...
(Date:1/16/2017)... ... January 16, 2017 , ... Permobil has ... Reflection® brand of custom seating systems has a well-earned reputation for premium quality, ... platform for innovation and growth in the custom seating business, which enjoys strong ...
(Date:1/16/2017)... ... January 16, 2017 , ... Date aired: ... http://www.ageofautism.com/legal , Sharon Kleyne, America’s leading water educator, researcher and advocate welcomed ... radio program, The Sharon Kleyne Hour Power of Water, Global Climate Change and ...
(Date:1/16/2017)... Francisco, CA (PRWEB) , ... January 16, 2017 , ... ... incorporation of iTero Element, the latest in 3-D scanning device which is capable of ... of the latest advances in dentistry, such as CAD CAM restorations , in ...
Breaking Medicine News(10 mins):